Related references
Note: Only part of the references are listed.Emicizumab Prophylaxis in Hemophilia A with Inhibitors
Johannes Oldenburg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Impact of inhibitors on hemophilia A mortality in the United States
Christopher E. Walsh et al.
AMERICAN JOURNAL OF HEMATOLOGY (2015)
Factor VIII inhibitors in hemophilia A: rationale and latest evidence
Char Witmer et al.
THERAPEUTIC ADVANCES IN HEMATOLOGY (2013)
A bispecific antibody to factors IXa and X restores factor VIII hemostatic activity in a hemophilia A model
Takehisa Kitazawa et al.
NATURE MEDICINE (2012)
Anti-Inhibitor Coagulant Complex Prophylaxis in Hemophilia with Inhibitors
Cindy Leissinger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Early long-term FEIBA prophylaxis in haemophilia A patients with inhibitor after failing immune tolerance induction: A prospective clinical case series
C. Escuriola Ettingshausen et al.
HAEMOPHILIA (2010)
Differential response to bypassing agents complicates treatment in patients with haemophilia and inhibitors
E. Berntorp
HAEMOPHILIA (2009)
European Study on Orthopaedic Status of haemophilia patients with inhibitors
M. Morfini et al.
HAEMOPHILIA (2007)
Randomized, prospective clinical trial of recombinant factor VIIa for secondary prophylaxis in hemophilia patients with inhibitors
B. A. Konkle et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Share Paper
